作为多功能抗老年联体的迪奥斯梅丁衍生物:设计,合成和生物评估
Aihong Yang1,2, Xiaoyue Yi1, Hongwei Zhang1
1School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Chemical biology & drug design
|April 26, 2024
概括
开发了四种新的迪奥斯梅丁衍生物,作为潜在的阿尔茨海默病 (AD) 治疗方法. 化合物3表现出强烈的胆酶抑制和降低粉样β聚合,显示AD治疗的希望.
科学领域:
- 药用化学 医学化学
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 由于人口老龄化,阿尔茨海默病 (AD) 构成了越来越大的挑战.
- 开发有效的,多功能药物用于AD治疗是一个关键的研究领域.
- 狄奥斯梅丁衍生物为新型治疗剂提供了有希望的支架.
研究的目的:
- 设计,合成和评估新型的迪奥斯美丁衍生物作为潜在的阿尔茨海默氏症多标配体.
- 为了研究这些化合物的胆酶抑制,金属化,抗氧化和抗胺β聚合活性.
- 评估它们的血脑屏障透性和体内疗效.
主要方法:
- 使用NMR和MS.合成和表征四种迪奥斯美丁衍生物 (1-4) .
- 分子对接研究以验证设计策略.
- 在体外评估生物活性:胆酶抑制 (AChE,BuChE),Cu2+化,抗氧化能力和Aβ聚合抑制.
- 评估血脑屏障的透性和细胞毒性.
- 在体内评估Caenorhabditis elegans中的活性氧物种 (ROS) 水平.
主要成果:
- 所有合成的衍生物 (1-4) 都显著抑制了乙胆酶 (AChE) 和丁胆酶 (BuChE).
- 化合物显示有选择性的金属化 (Cu2+),抗氧化特性,以及抑制Aβ聚合.
- 化合物3显示了对ACHE (10-8M) 和BuChE (10-7M) 的最强烈的抑制.
- 化合物3有效抑制了ACHE诱导的Aβ聚合 (66.14%) 并降低了低细胞毒性C. elegans细胞内ROS.
结论:
- 合成的迪奥斯梅丁衍生物是阿尔茨海默病的有效多目标联结体.
- 化合物3由于其强大的酶抑制,抗聚合和抗氧化活性,显示出作为AD治疗剂的显著潜力.
- 对化合物3进行进一步的研究是有必要的,以使其成为一种新的抗老年痴呆症候选药物.
相关概念视频
Structure-Activity Relationships and Drug Design
708
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
708
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.0K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.0K
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Olefin Metathesis Polymerization: Acyclic Diene Metathesis (ADMET)
1.9K
Acyclic diene metathesis polymerization or ADMET polymerization involves cross-metathesis of terminal dienes, such as 1,8-nonadiene, to give linear unsaturated polymer and ethylene. As ADMET is a reversible process, the formed ethylene gas must be removed from the reaction mixture to complete the polymerization process.
Similar to cross-metathesis, ADMET also involves the formation of metallacyclobutane intermediate by [2+2] cycloaddition of one of the double bonds of a terminal diene with...
Similar to cross-metathesis, ADMET also involves the formation of metallacyclobutane intermediate by [2+2] cycloaddition of one of the double bonds of a terminal diene with...
1.9K
Ligand Binding Sites
12.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K


